IL17A and neoplasm: Transfecting IL-17 into hepatocellular carcinoma cells significantly promotes neoangiogenesis, neutrophils recruitment, and tumor growth via AKT-dependent IL-6/JAK2/STAT3 signaling pathway in vivo [38].